Ignite Creation Date:
2025-12-25 @ 4:53 AM
Ignite Modification Date:
2025-12-26 @ 3:54 AM
Study NCT ID:
NCT04803318
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2021-03-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors
Sponsor:
Second Affiliated Hospital of Guangzhou Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2029-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2037-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-15
First Submit QC Date:
None
Study First Post Date:
2021-03-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-22
Last Update Post Date:
2024-06-25
Last Update Post Date Type:
ACTUAL